Inhibition of β(s)-chain dependent polymerization by synergistic complementation of contact site perturbations of α-chain: Application of semisynthetic chimeric α-chains

Sonati Srinivasulu, Ashok Malavalli, Muthuchidambaran Prabhakaran, Ronald L. Nagel, A. Seetharama Acharya

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Mouse α1-30-horse α31-141 chimeric α-chain, a semisynthetic super-inhibitory α-chain, inhibits β(s)-chain dependent polymerization better than both parent α-chains. Although contact site sequence differences are absent in the α1-30 region of the chimeric chain, the four sequence differences of the region α17-22 could induce perturbations of the side chains at α16, α20 and α23, the three contact sites of the region. A synergistic complementation of such contact site perturbation with that of horse α31-141 probably results in the super-inhibitory activity of the chimeric α-chain. The inhibitory contact site sequence differences, by themselves, could also exhibit similar synergistic complementation. Accordingly, the polymerization inhibitory activity of Hb Le-Lamentin (LM) mutation [His20(α)→Gln], a contact site sequence difference, engineered into human-horse chimeric α-chain has been investigated to map such a synergistic complementation. Gln20(α) has little effect on the O2 affinity of HbS, but in human-horse chimeric α-chain it reduces the O2 affinity slightly. In the chimeric α-chain, Gln20(cl) increased sensitivity of the ββ cleft for the DPG influence, reflecting a cross-talk between the α1β1 interface and ββ cleft in this semisynthetic chimeric HbS. In the human α-chain frame, the polymerization inhibitory activity of Gln20(α) is higher compared with horse α1-30, but lower than mouse α1-30. Gln20(α) synergistically complements the inhibitory propensity of horse α31-141. However, the inhibitory activity of LM-horse chimeric α-chain is still lower than that of mouse-horse chimeric α-chain. Therefore, perturbation of multiple contact sites in the α1-30 region of the mouse-horse chimeric α-chain and its linkage with the inhibitory propensity of horse α31-141 has been now invoked to explain the super-inhibitory activity of the chimeric α-chain. The 'linkage-map' of contact sites can serve as a blueprint for designing synergistic complementation of multiple contact sites into α-chains as a strategy for generating super-inhibitory antisickling hemoglobins for gene therapy of sickle cell disease.

Original languageEnglish (US)
Pages (from-to)1105-1111
Number of pages7
JournalProtein Engineering
Volume12
Issue number12
StatePublished - 1999

Fingerprint

Polymerization
Horses
Gene therapy
Blueprints
Hemoglobin
Hemoglobins
Sickle Cell Anemia
Genetic Therapy
Mutation
hemoglobin Le Lamentin

Keywords

  • Chimeric HbS
  • HbS polymerization
  • Intermolecular contact sites
  • Linkage map
  • Protein engineering
  • Super-inhibitory α-chain

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry

Cite this

Inhibition of β(s)-chain dependent polymerization by synergistic complementation of contact site perturbations of α-chain : Application of semisynthetic chimeric α-chains. / Srinivasulu, Sonati; Malavalli, Ashok; Prabhakaran, Muthuchidambaran; Nagel, Ronald L.; Acharya, A. Seetharama.

In: Protein Engineering, Vol. 12, No. 12, 1999, p. 1105-1111.

Research output: Contribution to journalArticle

Srinivasulu, Sonati ; Malavalli, Ashok ; Prabhakaran, Muthuchidambaran ; Nagel, Ronald L. ; Acharya, A. Seetharama. / Inhibition of β(s)-chain dependent polymerization by synergistic complementation of contact site perturbations of α-chain : Application of semisynthetic chimeric α-chains. In: Protein Engineering. 1999 ; Vol. 12, No. 12. pp. 1105-1111.
@article{abaa71141fc24df38bacd79a7ed1e485,
title = "Inhibition of β(s)-chain dependent polymerization by synergistic complementation of contact site perturbations of α-chain: Application of semisynthetic chimeric α-chains",
abstract = "Mouse α1-30-horse α31-141 chimeric α-chain, a semisynthetic super-inhibitory α-chain, inhibits β(s)-chain dependent polymerization better than both parent α-chains. Although contact site sequence differences are absent in the α1-30 region of the chimeric chain, the four sequence differences of the region α17-22 could induce perturbations of the side chains at α16, α20 and α23, the three contact sites of the region. A synergistic complementation of such contact site perturbation with that of horse α31-141 probably results in the super-inhibitory activity of the chimeric α-chain. The inhibitory contact site sequence differences, by themselves, could also exhibit similar synergistic complementation. Accordingly, the polymerization inhibitory activity of Hb Le-Lamentin (LM) mutation [His20(α)→Gln], a contact site sequence difference, engineered into human-horse chimeric α-chain has been investigated to map such a synergistic complementation. Gln20(α) has little effect on the O2 affinity of HbS, but in human-horse chimeric α-chain it reduces the O2 affinity slightly. In the chimeric α-chain, Gln20(cl) increased sensitivity of the ββ cleft for the DPG influence, reflecting a cross-talk between the α1β1 interface and ββ cleft in this semisynthetic chimeric HbS. In the human α-chain frame, the polymerization inhibitory activity of Gln20(α) is higher compared with horse α1-30, but lower than mouse α1-30. Gln20(α) synergistically complements the inhibitory propensity of horse α31-141. However, the inhibitory activity of LM-horse chimeric α-chain is still lower than that of mouse-horse chimeric α-chain. Therefore, perturbation of multiple contact sites in the α1-30 region of the mouse-horse chimeric α-chain and its linkage with the inhibitory propensity of horse α31-141 has been now invoked to explain the super-inhibitory activity of the chimeric α-chain. The 'linkage-map' of contact sites can serve as a blueprint for designing synergistic complementation of multiple contact sites into α-chains as a strategy for generating super-inhibitory antisickling hemoglobins for gene therapy of sickle cell disease.",
keywords = "Chimeric HbS, HbS polymerization, Intermolecular contact sites, Linkage map, Protein engineering, Super-inhibitory α-chain",
author = "Sonati Srinivasulu and Ashok Malavalli and Muthuchidambaran Prabhakaran and Nagel, {Ronald L.} and Acharya, {A. Seetharama}",
year = "1999",
language = "English (US)",
volume = "12",
pages = "1105--1111",
journal = "Protein Engineering, Design and Selection",
issn = "1741-0126",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Inhibition of β(s)-chain dependent polymerization by synergistic complementation of contact site perturbations of α-chain

T2 - Application of semisynthetic chimeric α-chains

AU - Srinivasulu, Sonati

AU - Malavalli, Ashok

AU - Prabhakaran, Muthuchidambaran

AU - Nagel, Ronald L.

AU - Acharya, A. Seetharama

PY - 1999

Y1 - 1999

N2 - Mouse α1-30-horse α31-141 chimeric α-chain, a semisynthetic super-inhibitory α-chain, inhibits β(s)-chain dependent polymerization better than both parent α-chains. Although contact site sequence differences are absent in the α1-30 region of the chimeric chain, the four sequence differences of the region α17-22 could induce perturbations of the side chains at α16, α20 and α23, the three contact sites of the region. A synergistic complementation of such contact site perturbation with that of horse α31-141 probably results in the super-inhibitory activity of the chimeric α-chain. The inhibitory contact site sequence differences, by themselves, could also exhibit similar synergistic complementation. Accordingly, the polymerization inhibitory activity of Hb Le-Lamentin (LM) mutation [His20(α)→Gln], a contact site sequence difference, engineered into human-horse chimeric α-chain has been investigated to map such a synergistic complementation. Gln20(α) has little effect on the O2 affinity of HbS, but in human-horse chimeric α-chain it reduces the O2 affinity slightly. In the chimeric α-chain, Gln20(cl) increased sensitivity of the ββ cleft for the DPG influence, reflecting a cross-talk between the α1β1 interface and ββ cleft in this semisynthetic chimeric HbS. In the human α-chain frame, the polymerization inhibitory activity of Gln20(α) is higher compared with horse α1-30, but lower than mouse α1-30. Gln20(α) synergistically complements the inhibitory propensity of horse α31-141. However, the inhibitory activity of LM-horse chimeric α-chain is still lower than that of mouse-horse chimeric α-chain. Therefore, perturbation of multiple contact sites in the α1-30 region of the mouse-horse chimeric α-chain and its linkage with the inhibitory propensity of horse α31-141 has been now invoked to explain the super-inhibitory activity of the chimeric α-chain. The 'linkage-map' of contact sites can serve as a blueprint for designing synergistic complementation of multiple contact sites into α-chains as a strategy for generating super-inhibitory antisickling hemoglobins for gene therapy of sickle cell disease.

AB - Mouse α1-30-horse α31-141 chimeric α-chain, a semisynthetic super-inhibitory α-chain, inhibits β(s)-chain dependent polymerization better than both parent α-chains. Although contact site sequence differences are absent in the α1-30 region of the chimeric chain, the four sequence differences of the region α17-22 could induce perturbations of the side chains at α16, α20 and α23, the three contact sites of the region. A synergistic complementation of such contact site perturbation with that of horse α31-141 probably results in the super-inhibitory activity of the chimeric α-chain. The inhibitory contact site sequence differences, by themselves, could also exhibit similar synergistic complementation. Accordingly, the polymerization inhibitory activity of Hb Le-Lamentin (LM) mutation [His20(α)→Gln], a contact site sequence difference, engineered into human-horse chimeric α-chain has been investigated to map such a synergistic complementation. Gln20(α) has little effect on the O2 affinity of HbS, but in human-horse chimeric α-chain it reduces the O2 affinity slightly. In the chimeric α-chain, Gln20(cl) increased sensitivity of the ββ cleft for the DPG influence, reflecting a cross-talk between the α1β1 interface and ββ cleft in this semisynthetic chimeric HbS. In the human α-chain frame, the polymerization inhibitory activity of Gln20(α) is higher compared with horse α1-30, but lower than mouse α1-30. Gln20(α) synergistically complements the inhibitory propensity of horse α31-141. However, the inhibitory activity of LM-horse chimeric α-chain is still lower than that of mouse-horse chimeric α-chain. Therefore, perturbation of multiple contact sites in the α1-30 region of the mouse-horse chimeric α-chain and its linkage with the inhibitory propensity of horse α31-141 has been now invoked to explain the super-inhibitory activity of the chimeric α-chain. The 'linkage-map' of contact sites can serve as a blueprint for designing synergistic complementation of multiple contact sites into α-chains as a strategy for generating super-inhibitory antisickling hemoglobins for gene therapy of sickle cell disease.

KW - Chimeric HbS

KW - HbS polymerization

KW - Intermolecular contact sites

KW - Linkage map

KW - Protein engineering

KW - Super-inhibitory α-chain

UR - http://www.scopus.com/inward/record.url?scp=0033434101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033434101&partnerID=8YFLogxK

M3 - Article

C2 - 10611404

AN - SCOPUS:0033434101

VL - 12

SP - 1105

EP - 1111

JO - Protein Engineering, Design and Selection

JF - Protein Engineering, Design and Selection

SN - 1741-0126

IS - 12

ER -